Aim: To determine the incidence of anemia in type-2 diabetic patients with normal renal function and assess the association of other factors related to diabetes with the risk of anemia. Methods: The study group comprised 72 patients with type-2 diabetes. Patients were divided into groups according to glycemic control, gender and age. Serum creatinine, hematocrit, hemoglobin concentration, blood glucose and glycated hemoglobin (HbA1c) of subjects were measured. The presence of anemia was defined by a hemoglobin level < 13.0 g/dL in men and <12.0 g/dL in women. Normal renal function (i.e. absence of renal impairment) was defined as serum creatinine level < 1.5 mg/dL. Results: 15.3% of the patients had anemia. The odds of developing anemia was higher in patients with poorly controlled diabetes (HbA1c > 7.5%) compared to those with controlled diabetes (≤7.5%) and in patients of age ≥ 60 yrs compared to those of age < 60 yrs (p < 0.05). The odds of anemia was similar in males and females (p = 0.26). Conclusion: This study indicated that poor glycemic control and old age are associated with the incidence of anemia in type-2 diabetics with normal renal function. Our findings suggest that treatment criteria for diabetes should include routine hematological tests and take into consideration the inevitable consequences of ageing, and poor glycemic control.

No abstract

Aim: The study aimed at evaluating the seroprevalence of H. pylori infection and its associated risk factors in a cross-section of asymptomatic adult population in Niger-Delta, Nigeria. Methodology: 408 apparently healthy volunteers, aged between 18 -87 years were recruited for this study. Blood samples were collected from participants and analyzed for H. pylori antibody (IgG) qualitatively with Combo rapid kits and quantitatively with Accu-Bind ELISA Kits. Results: The overall prevalence of Helicobacter pylori colonization in 408 asymptomatic adults was 52.5% (n = 214) and 48.3% (n = 197) by qualitative (Combo rapid kits) and quantitative (Accu-Bind ELISA Kits) serological test methods respectively. H. pylori infection did not differ statistically between genders (p = 0.962) and among age groups (p = 0.185). In addition, multivariate logistic regression indicated that sex and age were not associated with risk of H. pylori. However, participants from Delta Central were at greater risk (OR = 1.89; p = 0.014) of H. pylori infection compared with those from Delta South, but those from Delta North were not at greater risk of infection compared with those from Delta South (p = 0.476). Conclusion: This study indicated an intermediate seroprevalence of H. pylori among asymptoHow to cite this paper: Omosor, K.I.,

Objective: Cymbopogon citratus extract has been reported to have hypoglycemic properties but not much is known about its hypolipidemic effects. In this study it was aimed to demonstrate the hypolipidemic and hypoglycemic potentials of Cymbopogon citratus extract on alloxan-induced diabetic rats. Methods: Eighteen male albino rats of weights between 106-118 g were used for the study and divided into three groups of six rats each. The rats of the non-diabetic control group were given 1 ml of distilled water daily. Two other groups induced with diabetes using alloxan by a single dose administration of 120 mg/kg body weight (BW); one of these diabetic rat groups were treated with Cymbopogon citratus extract daily at 1.5 ml/100 g BW for 4 weeks while the other group was left untreated. Blood samples were collected and total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and glucose levels were assayed. Results: After four weeks of treatment, data indicated significant reductions in BW, blood glucose, TG, TC and LDL levels of diabetic rats treated with Cymbopogon citratus extract compared to the non-treated group. The treated diabetic rats also indicated significantly higher HDL levels compared to the non-treated group. Conclusion: Treatment of diabetic rats with the Cymbopogon citratus extract lowered blood glucose, TG, TC and LDL levels and increased the HDL level. This shows that the extract has both hypoglycemic and hypolipidemic effects. [J Exp Integr Med 2013; 3(3.000): 249-253

A drone is an aircraft controlled from a distance without a human pilot onboard using devices ingrained with software flight protocols. Outside the military, it lately just started to reach the relevancy of conventional businesses. The healthcare sector is an industry where this capacity is needed particularly in a pandemic in providing a responsive healthcare service in a contact-free manner. Also, delivery of blood supplies, vaccines, medications and other medical supplies to rural areas with no access to health facilities is made possible by the use of drones as they can navigate through difficult barriers such as buildings and bridges as well as areas that have been rendered inaccessible by conventional land and air transport. Drones have triggered a swift advancement in a variety of commercial, recreational and industrial applications with its capability to effectively put together real-time information on events at a low cost. However, its breakthrough in healthcare has been slower compared to other sectors where drones have been used extensively. Hence, this review is aimed at emphasizing the importance of drones in healthcare delivery noting its current and future usability. In this paper, a systematic review of relevant literatures was employed. Findings suggests that drones have been used effectively in healthcare viz a viz: enabling transportation of birth control, biopsy for emergency surgeries and other medical and laboratory supplies within few minutes. Considering the current global situation (COVID-19 pandemic), the future might experience more outpatient care and perhaps home-based care previously admitted in hospitals. Test results, medication­­s and other treatment ordered by physicians may be couriered to patient’s residence via drones. In conclusion, drones offer a variety of exciting opportunities; delivery of medical and laboratory supplies, blood products including biopsy for emergency surgeries is just a starting point. Drones have the capability to evolve medical care as well as propel advancement in the health industry.